Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITALITY-X: IV vs Topical Tranexamic Acid in Revision Hip Arthroplasty
NCT02938962Phase 4Unknown
- Sponsor
- Mount Sinai Hospital
- Start
- Oct 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tranexamic acid (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Change in Hemoglobin. Status: unknown.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT02938962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02938962.